The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Matrix metalloproteinase 13–deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development
Open accessAbstract
Objective: To investigate the role of matrix metalloproteinase 13 (MMP‐13; collagenase 3) in osteoarthritis (OA). Methods: OA was surgically induced in the knees of MMP‐13–knockout mice and wild‐type mice, and mice were compared. Histologic scoring of femoral and tibial cartilage aggrecan loss (0–3 scale), erosion (0–7 scale), and chondrocyte hypertrophy (0–1 scale), as well as osteophyte size (0–3 scale) and maturity (0–3 scale) was performed. Serial sections were stained for type X collagen and the MMP‐generated aggrecan neoepitope DIPEN. Results: Following surgery, aggrecan loss and cartilage erosion were more severe in the tibia than femur ( P < 0.01) and tibial cartilage erosion increased with time ( P < 0.05) in wild‐type mice. Cartilaginous osteophytes were present at 4 weeks and underwent ossification, with size and maturity increasing by 8 weeks ( P < 0.01). There was no difference between genotypes in aggrecan loss or cartilage erosion at 4 weeks. There was less tibial cartilage erosion in knockout mice than in wild‐type mice at 8 weeks ( P < 0.02). Cartilaginous osteophytes were larger in knockout mice at 4 weeks ( P < 0.01), but by 8 weeks osteophyte maturity and size were no different from those in wild‐type mice. Articular chondrocyte hypertrophy with positive type X collagen and DIPEN staining occurred in both wild‐type and knockout mouse joints. Conclusion: Our findings indicate that structural cartilage damage in a mouse model of OA is dependent on MMP‐13 activity. Chondrocyte hypertrophy is not regulated by MMP‐13 activity in this model and does not in itself lead to cartilage erosion. MMP‐13 deficiency can inhibit cartilage erosion in the presence of aggrecan depletion, supporting the potential for therapeutic intervention in established OA with MMP‐13 inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the early phases of OA, MMP-13 is predominantly expressed in the lower intermediate and deep layers of human and mouse cartilage, whereas aggrecanases are expressed in the superficial cartilage [25,26].”
From Arthropod steroid hormone (20-Hydroxyecdysone) suppresses IL-1β- induced catabolic gene expression in cartilage (2015) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glasson, S. S., Blanchet, T., & Morris, E. A. (2007) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.03.006 · Cited by 1,524
Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis
Glasson, S. S., Askew, R., Sheppard, B. J., Carito, B. A., Blanchet, T., Ma, H., Flannery, C. R., Peluso, D., Kanki, K., Yang, Z., et al. (2005) · Nature · doi:10.1038/nature03369 · Cited by 1,258
Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage.
Billinghurst, R. C., Dahlberg, L., Ionescu, M., Reiner, A., Bourne, R., Rorabeck, C. H., Mitchell, P. G., Hambor, J., Diekmann, O., Tschesche, H., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119316 · Cited by 970
ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro
Stanton, H., Rogerson, F. M., East, C. J., Golub, S. B., Lawlor, K. E., Meeker, C. T., Little, C. B., Last, K., Farmer, P. J., Campbell, I. K., et al. (2005) · Nature · doi:10.1038/nature03417 · Cited by 920
Self-citationMatrix Metalloproteinases as Modulators of Inflammation
MANICONE, A., & MCGUIRE, J. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2007.07.003 · Cited by 617
Altered endochondral bone development in matrix metalloproteinase 13-deficient mice
Stickens, D., Behonick, D. J., Ortéga, N., Heyer, B. S., Hartenstein, B., Yu, Y., Fosang, A., Schorpp‐Kistner, M., Angel, P. E., & Werb, Z. (2004) · Development · doi:10.1242/dev.01461 · Cited by 608
Self-citationOsteoarthritis development in novel experimental mouse models induced by knee joint instability
Kamekura, S., Hoshi, K., Shimoaka, T., Chung, U., Chikuda, H., Yamada, T., Uchida, M., Ogata, N., Seichi, A., Nakamura, K., et al. (2005) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2005.03.004 · Cited by 583
Inada, M., Wang, Y., Byrne, M. H., Rahman, M. U., Miyaura, C., López-Otı́n, C., & Krane, S. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407788101 · Cited by 576
Neuhold, L. A., Killar, L. M., Zhao, W., Sung, M.-L. A., Warner, L. F., Kulik, J., Turner, J. R., Wu, W. K. K., Billinghurst, C., Meijers, T. H. M., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10564 · Cited by 541
Aggrecanases and cartilage matrix degradation.
Nagase, H., & Kashiwagi, M. (2003) · Arthritis Research · doi:10.1186/ar630 · Cited by 420
Flagged first, then by citations
Research works printed but not linked: 1
- Ma HL, 2005, Disease progression in surgically induced murine osteoarthritis is strain and sex dependent, Trans Orth Res Soc, 30, 1422
Cited by
Sorted by citations
Osteoarthritis: A disease of the joint as an organ
Loeser, R. F., Goldring, S. R., Scanzello, C. R., & Goldring, M. B. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34453 · Cited by 3,234
Osteoarthritis: toward a comprehensive understanding of pathological mechanism
Chen, D., Shen, J., Zhao, W., Wang, T., Han, L., Hamilton, J. L., & Im, H. (2017) · Bone Research · doi:10.1038/boneres.2016.44 · Cited by 1,221
Osteoarthritis: pathogenic signaling pathways and therapeutic targets
Yao, Q., Wu, X., Tao, C., Gong, W., Chen, M., Qu, M., Zhong, Y., He, T., Chen, S., & Xiao, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01330-w · Cited by 1,194
Recent Updates of Diagnosis, Pathophysiology, and Treatment on Osteoarthritis of the Knee
Jang, S., Lee, K.-J., & Ju, J. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052619 · Cited by 879
Proteases involved in cartilage matrix degradation in osteoarthritis
Troeberg, L., & Nagase, H. (2011) · Biochimica et Biophysica Acta · doi:10.1016/j.bbapap.2011.06.020 · Cited by 599
Metadata
- Authors
- Little, C. B., Barai, A., Burkhardt, D., Smith, S. M., Fosang, A. J., Werb, Z., Shah, M., & Thompson, E. W.
- Affiliations
- The University of Sydney (AU)
- Royal Children's Hospital (AU)
- University of California, San Francisco (US)
- The University of Melbourne (AU)
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2009-11-30
- Volume
- 60
- Issue
- 12
- Pages
- 3723-3733
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- PMC
- PMC2832925
- OpenAlex
- W2060951121
- Cited by
- 642
- References
- 54
- Citations by year
- 2026: 26 · 2025: 36 · 2024: 39 · 2023: 38 · 2022: 43 · 2021: 42 · 2020: 59 · 2019: 42 · 2018: 35 · 2017: 46 · 2016: 41 · 2015: 42 · 2014: 34 · 2013: 36 · 2012: 29
- FWCI
- 18.84
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Arthritis & Rheumatism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Arthritis Australia
- National Institutes of Health
- Medical Research Council
- National Health and Medical Research Council (384414)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR046238, R01AR046238)
- Topics
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Keywords
- matrix metalloproteinase-13, collagenase-3, osteoarthritis, cartilage erosion, chondrocyte hypertrophy, osteophytes, type X collagen, MMP-13 inhibitors
- MeSH terms
- Animals, Arthritis, Experimental, Calcinosis, Cartilage, Articular, Femur, Hypertrophy, Joints, Male, Osteoarthritis, Tibia, Mice, Knockout, Chondrocytes, Mice, Matrix Metalloproteinase 13, Aggrecans, Osteophyte
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
